Peer Reviewed Publications:

1. NrasQ61R/+ and Kras-/- cooperate to downregulate Rasgrp1 and promote lympho-myeloid leukemia in early T-cell precursors Blood (2021) DOI (Featured in Blood Volume 137-Issue 23)

2. Expression of NrasQ61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice Blood (2020) DOI

3. Mice Expressing MYC and NrasQ61R in Germinal Center B Cells Develop Highly Aggressive Multiple Myeloma Blood (2018) 132 (Supplement 1): 1006. DOI

4. Expression of oncogenic Nras and a MYC transgene in germinal center B cells induces a highly malignant multiple myeloma American Association for Cancer Research Annual Meeting 2018; April 14-18, 2018; Chicago, IL DOI

5. FOXM1 regulates glycolysis and energy production in multiple myeloma Oncogene (2022) DOI

6. Tcof1 haploinsufficiency promotes early T cell precursor-like leukemia in NrasQ61R/+ mice Leukemia (2022) DOI

7. DNA methylation in circulating leukocytes is a novel biomarker in multiple myeloma Bone Marrow Transplantation (2022) DOI

8. Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy Bone Marrow Transplantation (2023) DOI